Beta Cross Laps

Beta cross laps analysis is a crucial procedure used for evaluating bone metabolism. This test detects the C-terminal part of type I collagen, a bone degradation product. With beta cross laps analysis, assessing the degree of bone resorption is possible, which is useful in diagnosing various bone diseases such as rickets and Paget’s disease.

Additionally, the beta cross laps analysis is an effective tool in evaluating the success of antiresorptive therapy in treating various bone diseases, including osteoporosis and hypercalcemia. Measuring the concentration of this parameter in the blood provides detailed insight into the state of bone resorption, allowing doctors to accurately monitor the disease’s progress and the therapy’s effectiveness.

Private laboratories in Belgrade, like our IntroLab, perform beta cross laps analysis using state-of-the-art technology and equipment. Our team of experts is dedicated to providing accurate and reliable results, enabling doctors to make appropriate therapy decisions for patients. Our mission is to provide the best possible care and support to every patient, and we are also proud that the cost of beta cross laps analysis is quite affordable.

What are the indications for beta cross laps analysis?

When there is suspicion of changed bone quality or certain symptoms and occurrences like frequent fractures, it is recommended to determine beta cross laps along with other bone markers. Conducting this blood analysis and determining levels of vitamin D, PTH, total calcium, and other biochemical markers is also advisable.

In children, beta cross laps can be useful in diagnosing metabolic diseases such as Paget’s disease, osteogenesis imperfecta (brittle bone disease), rickets, and others. However, it is always important to combine the results of beta cross laps analysis with imaging techniques or radiological examination of bones to confirm the diagnosis.

The most important application of beta cross laps analysis is in assessing the efficacy of antiresorptive therapy for bones, such as bisphosphonates or hormone replacement therapy, in conditions like osteoporosis or hypercalcemia from various causes. In these cases, beta cross laps determination is done at the start of therapy and then repeated after 2-3 weeks to evaluate the effectiveness of the therapy.